As on 02 Jul, 2025 | 01:29 IST
| Open | 73.52 |
| Previous Close | 73.55 |
| Beta | 0.54 |
| High | 75.73 |
| Low | 73.09 |
| TTM EPS See historical trend | 4.37(+21.39% YoY) |
| 52 Week High | 106.77 |
| 52 Week Low | 65.94 |
| TTM PE See historical trend | 17.19(Average PE) |
| Mkt. Cap ($ Billion) | 19.18 |
| Dividend Yield | 2.06 |
*Delayed by 20 seconds.
| Days | |
|---|---|
| 5 | 74.29 |
| 10 | 74.37 |
| 20 | 75.92 |
| 50 | 76.11 |
| 100 | 77.89 |
| 200 | 85.91 |
| 1 Week | 1.76% | |
| 1 Month | -1.92% | |
| 3 Months | -1.69% | |
| YTD | -11.13% | |
| 1 Year | -21.09% | |
| 3 Years | -36.93% |
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| P&G | 152.63 | 0.29 | 359.00 | 22.34 | 6.83 | 2.59 | 180.40/146.97 | 0.10 | Very Bearish |
| Coca-Cola | 69.74 | -0.29 | 300.49 | 23.87 | 2.92 | 2.83 | 74.37/60.63 | 4.91 | Very Bearish |
| McDonalds | 306.04 | -0.31 | 220.77 | 25.80 | 11.85 | 2.39 | 326.17/276.91 | 0.49 | Bullish |
| Sherwin-Williams | 333.58 | 0.69 | 84.87 | 30.12 | 11.09 | 0.88 | 400.33/309.37 | -2.61 | Very Bearish |
| Ecolab | 277.23 | 0.80 | 77.20 | 39.97 | 6.82 | 1.03 | 273.97/221.04 | 2.47 | Very Bullish |
International Flavors & Fragrances Inc. offers sensory, food and beverage, pharmaceutical, health and wellness, home and personal care solutions and ingredients. It operates through segments such as Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment consists portfolio of natural-based ingredients to improve nutritional value, texture and functionality in a range of beverage, dairy, bakery, confectionery and culinary applications. The Scent segment consists of its legacy Scent segment as well as its Flavor Ingredients business. The Health & Biosciences segment includes a biotechnology-driven probiotics portfolio, that produces cultures for use in fermented foods such as yogurt, cheese and fermented beverages. The Pharma Solutions segment consists of cellulosics and alginates-based pharma excipients.